Frank Casella (@casellaceo) 's Twitter Profile
Frank Casella

@casellaceo

CEO-Global Wellness Products LLC OTC:IMTL Life-long entrepreneur, business owner, innovator and investor. I don't believe in the "no-win" scenario! TALLY HO!

ID: 1938585083944022016

linkhttps://www.globalwellnessproducts.com/ calendar_today27-06-2025 13:08:06

86 Tweet

54 Followers

3 Following

Frank Casella (@casellaceo) 's Twitter Profile Photo

$IMTL Let's continue to talk about our market potential now that everything is in place and we are shipping InterceptCS™ to the U.S. market! #coldsores

$IMTL Let's continue to talk about our market potential now that everything is in place and we are shipping InterceptCS™ to the U.S. market! #coldsores
Frank Casella (@casellaceo) 's Twitter Profile Photo

$IMTL I posted this information recently but it bears repeating: 100 million cold sore outbreaks in the U.S. annually. That is on par with migraine headaches and allergies. If someone could stop migraines what would that value be? Same scenario here with InterceptCS™.

Frank Casella (@casellaceo) 's Twitter Profile Photo

$IMTL This is kind of mindless nonsense that has no place in our world. I suppose I've IMAGINED $600K worth of inventory? I've IMAGINED all of my personal investment in Review Control programming? And I'm IMAGINING our product placement and sales? Somebody jump on this clown.

$IMTL This is kind of mindless nonsense that has no place in our world. I suppose I've IMAGINED $600K worth of inventory? I've IMAGINED all of my personal investment in Review Control programming? And I'm IMAGINING our product placement and sales? Somebody jump on this clown.
Frank Casella (@casellaceo) 's Twitter Profile Photo

$IMTL After many months of planning and 80 hour work weeks, our unique product (the only one that can prevent the 100 million cold sore outbreaks annually) is available on our fantastic website as well as Amazon, Ebay and soon Walmart. And these yahoos do no homework on any of it

Frank Casella (@casellaceo) 's Twitter Profile Photo

$IMTL Amazing that so many of these wanna-be "traders" are hanging around looking for free money, know little to nothing about what we do here because they don't want to know. Making slanderous and untrue statements in their small, dark world. Elves in a tree didn't make this!

Frank Casella (@casellaceo) 's Twitter Profile Photo

$IMTL Good Friday Morning Munchkins! I hope you all have plans for a relaxing Labor Day Weekend. In this land of OZ (OTC PINK) I see varying opinions about a number of subjects regarding our endevors here at $IMTL. Our plan is solid and the table is set now. More news next week!

Frank Casella (@casellaceo) 's Twitter Profile Photo

$IMTL Time to debunk another deranged consipiracy theory! Apparently there have been some questionable posts to the thread from "bots" (not sure how that works to be honest). I am far too busy expanding the Company to engage in somethinig so ridiculous as that. Usual suspects too

Frank Casella (@casellaceo) 's Twitter Profile Photo

$IMTL Let's all continue to understand the mission. Based upon the size of the problem of cold sores, and the fact that we have the only Approved preventative product, our realistic goal for sales ($99 plus Activator replacement orders) you can do the math for yourself!

$IMTL Let's all continue to understand the mission. Based upon the size of the problem of cold sores, and the fact that we have the only Approved preventative product, our realistic goal for sales ($99 plus Activator replacement orders) you can do the math for yourself!
Frank Casella (@casellaceo) 's Twitter Profile Photo

$IMTL So you are all preched like wildebeasts at waters edge, waiting for some catalyst to improve your personal positions with only that singular, selfish motive. Our capital goes into inventory and operations, not buying stock so that you can score. Stop complaining.

Frank Casella (@casellaceo) 's Twitter Profile Photo

$IMTL The Musk comparison is absolutely ridiculous. We don't have that market cap, nor are we at $440. per share. We are a small company with big upside growth potential. That's it. No federal subsidies, no magic tricks, just a lot of my presonal $$ invested and lots of hard work

Frank Casella (@casellaceo) 's Twitter Profile Photo

$IMTL As I have said many times, the 2 ways to share profitability with shareholders is to either A. Pay a Dividend, or B. Buy back shares. When we get there we will be happy to entertain buy back options. Right now we're building out the marketing footprint, takes time and $$!

Frank Casella (@casellaceo) 's Twitter Profile Photo

$IMTL AND I'm going to say this for the LAST time! Diverting capital at this juncture to appease a "no bid" angst or to create profit for short-term traders who have no real interest in the Company or its mission, would be a terrible mismanagement of capital! Go long or go home!

Frank Casella (@casellaceo) 's Twitter Profile Photo

$IMTL Good Monday Morning Muchkins! We have been working diligently on identifying best channels for product marketing and are preparing a special program for 4th quarter! Everything is moving along nicely and we appreciate your support! Remember the potential of the market!!

$IMTL Good Monday Morning Muchkins! We have been working diligently on identifying best channels for product marketing and are preparing a special program for 4th quarter! Everything is moving along nicely and we appreciate your support! Remember the potential of the market!!
Frank Casella (@casellaceo) 's Twitter Profile Photo

$IMTL As many of you are aware, our long-term mission is to really help millions of cold sore sufferers with our innovative technology. Cold sores are on par with the number of migraine headaches in the U.S.! It isn't rocket science to anticipate serious numbers for InterceptCS™

$IMTL As many of you are aware, our long-term mission is to really help millions of cold sore sufferers with our innovative technology. Cold sores are on par with the number of migraine headaches in the U.S.! It isn't rocket science to anticipate serious numbers for InterceptCS™
Frank Casella (@casellaceo) 's Twitter Profile Photo

$IMTL Apparently not everyone is aware of our business model, which is identical to Gillette. Our revenue projections are based upon refill orders for Thermal Activators. The price point of the device itself (much like the Gillette razor w/ 2 cartridges) is currently being tested

Frank Casella (@casellaceo) 's Twitter Profile Photo

$IMTL Our Thermal Activator refill orders are very satsfactory at this stage. Our goal is conversion on the front side with attractive pricing for new users. I would recommend everyone refresh their memory: imageprotectcorp.com/a-message-from…

Frank Casella (@casellaceo) 's Twitter Profile Photo

$IMTL Once our initial price point testing is completed we will update all known platforms with our bundle offer. This should be easy to understand. Our production costs enable us to be profitable at ANY price point. Next time you put a new cartidge in your razor, think of me!

Frank Casella (@casellaceo) 's Twitter Profile Photo

$IMTL It pains me to have to keep explaining these simple concepts over and over. Every successful product has gone through this process. Our advertising to drive site traffic is very targeted for price testing and conversion percentage. It's about hitting the magic number.

Frank Casella (@casellaceo) 's Twitter Profile Photo

$IMTL Great news! The Canadian Postal strike has been settled and deliveries have resumed. This is important because it allows us to re-activate our advertising campaigns in Canada, where InterceptCS™ is widely accepted and Health Canada Approved, and our deliveries have resumed

Frank Casella (@casellaceo) 's Twitter Profile Photo

$IMTL We also have a good number of customers in Canada from the previous sales of InterceptCS™ and servicing them with Thermal Activator reorders is part of our responsibility in our contract with ThermaBright. Cold weather is a factor as cold sores are more prevalent in winter